JMP Securities has reaffirmed its Market Outperform rating and a price target of $41.00 on Exelixis stock (NASDAQ:EXEL), aligning with the broader analyst consensus that sees upside potential.

JMP Securities reiterated its Market Outperform rating and $7.00 price target for Esperion Therapeutics (NASDAQ:ESPR) stock, ...

JMP Securities analyst Aaron Hecht maintained a Hold rating on AFC Gamma (AFCG – Research Report) today. The company’s shares closed yesterday ...

JMP Securities analyst Matthew Carletti reiterated a Hold rating on RLI (RLI – Research Report) today. The company’s shares closed yesterday at ...